Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Endometriosis Market, by Type
1.4.2 Europe Endometriosis Market, by Treatment
1.4.3 Europe Endometriosis Market, by Distribution Channel
1.4.4 Europe Endometriosis Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Endometriosis Market by Type
3.1 Europe Superficial Peritoneal Lesion Market by Country
3.2 Europe Endometriomas Market by Country
3.3 Europe Others Market by Country
Chapter 4. Europe Endometriosis Market by Treatment
4.1 Europe Oral Contraceptives Market by Country
4.2 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Endometriosis Market by Distribution Channel
5.1 Europe Hospital Pharmacy Market by Country
5.2 Europe Retail Pharmacy Market by Country
5.3 Europe Online Pharmacy Market by Country
Chapter 6. Europe Endometriosis Market by Country
6.1 Germany Endometriosis Market
6.1.1 Germany Endometriosis Market by Type
6.1.2 Germany Endometriosis Market by Treatment
6.1.3 Germany Endometriosis Market by Distribution Channel
6.2 UK Endometriosis Market
6.2.1 UK Endometriosis Market by Type
6.2.2 UK Endometriosis Market by Treatment
6.2.3 UK Endometriosis Market by Distribution Channel
6.3 France Endometriosis Market
6.3.1 France Endometriosis Market by Type
6.3.2 France Endometriosis Market by Treatment
6.3.3 France Endometriosis Market by Distribution Channel
6.4 Russia Endometriosis Market
6.4.1 Russia Endometriosis Market by Type
6.4.2 Russia Endometriosis Market by Treatment
6.4.3 Russia Endometriosis Market by Distribution Channel
6.5 Spain Endometriosis Market
6.5.1 Spain Endometriosis Market by Type
6.5.2 Spain Endometriosis Market by Treatment
6.5.3 Spain Endometriosis Market by Distribution Channel
6.6 Italy Endometriosis Market
6.6.1 Italy Endometriosis Market by Type
6.6.2 Italy Endometriosis Market by Treatment
6.6.3 Italy Endometriosis Market by Distribution Channel
6.7 Rest of Europe Endometriosis Market
6.7.1 Rest of Europe Endometriosis Market by Type
6.7.2 Rest of Europe Endometriosis Market by Treatment
6.7.3 Rest of Europe Endometriosis Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.3 Sun Pharmaceutical Industries Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.4 Sanofi S.A.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 AbbVie, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Trials and Approvals:
7.6 AstraZeneca PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Pfizer, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional & Segmental Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Trials and Approvals:
7.8 Merck & Co., Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 Recent strategies and developments:
7.8.5.1 Trials and Approvals:
7.9 GlaxoSmithKline PLC
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Trials and Approvals:
7.9.5.2 Acquisition and Mergers:
7.10. Consilient Health Limited
7.10.1 Company Overview
Unique Offerings 